# Murty Pharmaceuticals, Inc - Inspection Records

Source: https://www.globalkeysolutions.net/companies/murty-pharmaceuticals-inc/8d7f8024-f6fd-463e-b94f-63cd3b745e96

> Inspection records and compliance data for Murty Pharmaceuticals, Inc in Lexington, Kentucky. Access full analysis and detailed observations.

---

## Details

- Name: Murty Pharmaceuticals, Inc
- FEI Number: 1000515343
- City: Lexington
- State: Kentucky
- Country Name: United States
- Address Line 1: 518 Codell Dr
- Zip Code: 40509
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - Murty Pharmaceuticals, Inc - 2025-03-28](https://www.globalkeysolutions.net/records/483/murty-pharmaceuticals-inc/17913da3-13d5-4315-a8de-444ab84c9681) — source: FDA, date: March 28, 2025
- [FDA Inspection 1265169 - Murty Pharmaceuticals, Inc - 2025-03-28](https://www.globalkeysolutions.net/records/fda_inspections/murty-pharmaceuticals-inc/2b083c05-1eac-4b54-8466-47d2b64e2225) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 28, 2025
- [FDA Inspection 1077569 - Murty Pharmaceuticals, Inc - 2019-01-14](https://www.globalkeysolutions.net/records/fda_inspections/murty-pharmaceuticals-inc/3ebe0ae6-738d-4fde-9513-77cb4e512f45) — classification: No Action Indicated (NAI), source: FDA, date: January 14, 2019
- [FDA Inspection 858433 - Murty Pharmaceuticals, Inc - 2013-11-15](https://www.globalkeysolutions.net/records/fda_inspections/murty-pharmaceuticals-inc/a5af8968-63ad-4ce8-91c8-67bb725bc7f0) — classification: No Action Indicated (NAI), source: FDA, date: November 15, 2013
- [FDA Inspection 732158 - Murty Pharmaceuticals, Inc - 2011-06-22](https://www.globalkeysolutions.net/records/fda_inspections/murty-pharmaceuticals-inc/6f346e2f-292f-4d21-ad17-acc42d8d2f72) — classification: No Action Indicated (NAI), source: FDA, date: June 22, 2011
- [FDA Inspection 680956 - Murty Pharmaceuticals, Inc - 2010-09-14](https://www.globalkeysolutions.net/records/fda_inspections/murty-pharmaceuticals-inc/30f3ebdb-e5a7-4e19-9b95-0977b973b30d) — classification: No Action Indicated (NAI), source: FDA, date: September 14, 2010

## Related Companies

- [ZYDUS LIFESCIENCES LIMITED](https://www.globalkeysolutions.net/companies/zydus-lifesciences-limited/aa40e2a7-c250-4524-b05f-6ca311474c5c)
- [Lead Chemical Co., Ltd.](https://www.globalkeysolutions.net/companies/lead-chemical-co-ltd/b8997674-3f8e-4cd9-8f7d-1c677f4ea0f0)
- [Zydus Lifesciences Limited](https://www.globalkeysolutions.net/companies/zydus-lifesciences-limited/1715db78-d88c-4e31-a5e0-cf81fb62411b)
- [Tedor Pharma, Inc.](https://www.globalkeysolutions.net/companies/tedor-pharma-inc/a9fa17c4-23c1-4bcf-ad03-bb9635bb063d)
- [Rockledge Pharmaceutical Manufacturing LLC](https://www.globalkeysolutions.net/companies/rockledge-pharmaceutical-manufacturing-llc/a5456e96-65d2-4f19-ba2f-e7cb72b32922)
- [Catalent Argentina S.A.I.C.](https://www.globalkeysolutions.net/companies/catalent-argentina-saic/c4e097df-85fe-4836-9778-b395fe1e78de)
- [MW Encap Ltd.(NextPharma Edinburgh)](https://www.globalkeysolutions.net/companies/mw-encap-ltdnextpharma-edinburgh/e8cf1af5-d17a-4c79-ba7d-498a371fbc50)
- [Conopco, Inc](https://www.globalkeysolutions.net/companies/conopco-inc/7ea57e14-27dd-432e-a45a-5af402cdb9e5)
- [Zydus Lifesciences Limited](https://www.globalkeysolutions.net/companies/zydus-lifesciences-limited/0de1df3a-c70c-43b9-9a35-4aac9b0413f4)
- [Shire Human Genetic Therapies, Inc.](https://www.globalkeysolutions.net/companies/shire-human-genetic-therapies-inc/7051823d-8cc7-4d72-8a82-a0de9bbb9497)

## Related Officers

- [Heather R. Campbell](https://www.globalkeysolutions.net/people/heather-r-campbell/aaf80125-4322-45fe-a0f6-30cea8f1dbd2)
- [investigator](https://www.globalkeysolutions.net/people/geoffrey-k-kilili/b00aeedf-95bd-4ccf-a23e-6e12e60249c4)